US 7507861
Process for the preparation of atomoxetine hydrochloride
granted A61PA61P25/00A61P43/00
Quick answer
US patent 7507861 (Process for the preparation of atomoxetine hydrochloride) held by Teva Pharmaceutical Fine Chemicals S.R.L. expires Mon Mar 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Teva Pharmaceutical Fine Chemicals S.R.L.
- Grant date
- Tue Mar 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61P, A61P25/00, A61P43/00